Biliary cystadenoma and cystadenocarcinoma screening

Biliary cystadenoma and cystadenocarcinoma Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Biliary cystadenoma and cystadenocarcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Biliary cystadenoma and cystadenocarcinoma screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Biliary cystadenoma and cystadenocarcinoma screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Biliary cystadenoma and cystadenocarcinoma screening
CDC on Biliary cystadenoma and cystadenocarcinoma screening
Biliary cystadenoma and cystadenocarcinoma screening in the news
Blogs on Biliary cystadenoma and cystadenocarcinoma screening
Directions to Hospitals Treating Biliary cystadenoma and cystadenocarcinoma
Risk calculators and risk factors for Biliary cystadenoma and cystadenocarcinoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for biliary cystadenoma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for biliary cystadenoma.